Patents by Inventor Min Hyung Kang

Min Hyung Kang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250170170
    Abstract: Provided is a bowel-cleansing composition comprising anhydrous magnesium sulfate, potassium sulfate, and anhydrous sodium sulfate, in combination with prucalopride or sodium picosulfate.
    Type: Application
    Filed: November 28, 2023
    Publication date: May 29, 2025
    Applicant: DAEWOONG THERAPEUTICS INC.
    Inventors: Sang Han PARK, Min Hyung KANG, Hyun Ju CHOI, Seung Jun KANG, Sun Yong YANG
  • Publication number: 20240055303
    Abstract: A fabricating method for a test element group is provided. The fabricating method for a test element group includes fabricating test areas generated in a scribe lane area, wherein fabricating of the test areas includes forming a plurality of fins protruding in a first direction on a substrate, covering at least some of the plurality of fins with a masking material, and performing selective epitaxial growth by injecting a gas onto the plurality of fins. The gas is not injected onto the at least some of the plurality of fins that are covered with the masking material, such that the epitaxial growth does not occur on the fins covered with the masking material.
    Type: Application
    Filed: March 7, 2023
    Publication date: February 15, 2024
    Inventors: Sun Woo KIM, Min Hyung KANG, Min Seob KIM, Chan Geun AHN
  • Patent number: 6699689
    Abstract: The present invention relates to DNA constructs that can produce antimicrobial materials efficiently from microorganisms and the preparation method thereof. The present invention also relates to the useful vector for the DNA construct. The DNA construct according to the present invention comprises a first gene coding for entire, a part of or a derivative of purF gene and a second gene coding for antimicrobial peptide. According to the present invention, antimicrobial peptides can be mass-produced by the following steps: preparing an expression vector containing a DNA construct comprising a first gene coding for an entire, a part of or a derivative of purF gene and a second gene coding for antimicrobial peptide; transforming the bacterial host cells with the above-mentioned vector, culturing the transformed cell to express the above-mentioned DNA construct; and recovering the above antimicrobial peptide.
    Type: Grant
    Filed: April 25, 2000
    Date of Patent: March 2, 2004
    Assignee: Samyang Genex Corporation
    Inventors: Jeong Hyun Kim, Min Hyung Kang, Jae Hyun Lee, Se Ho Park, Joo Won Lee, Seung Suh Hong, Hyun Soo Lee
  • Patent number: 6183992
    Abstract: The present invention provides a method for mass production of an antimicrobial peptide, which comprises the steps of: constructing a fusion gene containing a first gene encoding a negatively charged acidic peptide having at least two cysteine residues and a second gene encoding a positively charged basic antimicrobial peptide; transforming a host microorganism with an expression vector comprising the fusion gene; cultivating the transformed microorganism to express a fusion peptide containing the acidic peptide and antimicrobial peptide, and, recovering the expressed antimicrobial peptide. In accordance with the present invention, the inhibitory effect of the expressed antimicrobial peptide on the growth of the host microorganism can be dramatically minimized by fusing it with the acidic peptide. Accordingly, antimicrobial peptides can be produced massively from a recombinant microorganism regardless of the kind of the antimicrobial peptides.
    Type: Grant
    Filed: March 10, 1999
    Date of Patent: February 6, 2001
    Assignees: Samyang Genex Corporation, Korea Advanced Institute of Science and Technology
    Inventors: Sun-Chang Kim, Jae Hyun Lee, Min Hyung Kang, Jeong Hyun Kim, Seung-Suh Hong, Hyun-Soo Lee